NGM Biopharmaceuticals, Inc.
Methods of using compositions comprising variants and fusions of FGF 19 polypeptides for treating diabetes
Last updated:
Abstract:
The invention relates to methods of using variants and fusions of fibroblast growth factor 19 (FGF19) for treating diabetes.
Status:
Grant
Type:
Utility
Filling date:
10 Apr 2018
Issue date:
1 Sep 2020